Published in J Nanobiotechnology on April 05, 2014
Development of a three-dimensional cell culture system based on microfluidics for nuclear magnetic resonance and optical monitoring. Biomicrofluidics (2014) 0.76
In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2017) 0.75
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev (1999) 12.52
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials (2005) 11.01
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev (2008) 8.23
Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev (2006) 4.69
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev (2006) 4.27
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev (2009) 4.06
Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev (2008) 3.34
Transport of sugars in tumor cell membranes. Biochim Biophys Acta (1974) 2.72
EuroPhenome and EMPReSS: online mouse phenotyping resource. Nucleic Acids Res (2007) 2.54
Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging (2009) 2.48
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging (1999) 2.07
Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging (2006) 1.97
Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. Radiology (2005) 1.94
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc Chem Res (2009) 1.94
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol (2010) 1.89
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med (2004) 1.83
Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med (1995) 1.65
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc (2007) 1.57
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine (2007) 1.49
Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles. Proc Natl Acad Sci U S A (2009) 1.43
Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. Biochim Biophys Acta (2005) 1.42
Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. Radiology (2004) 1.42
Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.35
From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res (2010) 1.33
Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int J Nanomedicine (2008) 1.28
Gold glyconanoparticles as new tools in antiadhesive therapy. Chembiochem (2004) 1.25
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer (2003) 1.23
Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions This work was supported by the DGICYT (PB96-0820), J.M.F. thanks the MEC for a predoctoral fellowship. A.G.B. thanks CSIC for financial support. We thank Prof. Martín-Lomas for his scientific and financial support. Angew Chem Int Ed Engl (2001) 1.21
Age-Related Reference Intervals of the Main Biochemical and Hematological Parameters in C57BL/6J, 129SV/EV and C3H/HeJ Mouse Strains. PLoS One (2008) 1.19
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer (2008) 1.18
Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J Biophotonics (2009) 1.17
Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev (2013) 1.13
Efficient stem cell labeling for MRI studies. Contrast Media Mol Imaging (2008) 1.07
High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjug Chem (2002) 1.05
Gold-silver alloy nanoshells: a new candidate for nanotherapeutics and diagnostics. Nanoscale Res Lett (2011) 0.91
Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging. Pharm Res (2007) 0.91
Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Invest Radiol (2009) 0.89
Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem (2010) 0.89
Shuttle-mediated drug delivery to the brain. Angew Chem Int Ed Engl (2011) 0.89
Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia. NMR Biomed (2008) 0.89
DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data. BMC Bioinformatics (2013) 0.88
Glyconanoparticles: multifunctional nanomaterials for biomedical applications. Nanomedicine (Lond) (2010) 0.87
New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer. J Biol Inorg Chem (2009) 0.85
Determination of in vivo rat muscle Gd-DTPA relaxivity at 6.3 T. MAGMA (1999) 0.84
Modulating glycosidase degradation and lectin recognition of gold glyconanoparticles. Carbohydr Res (2009) 0.84
High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin. Chemistry (2008) 0.83
Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars. Chem Commun (Camb) (2009) 0.81
An iron-based T1 contrast agent made of iron-phosphate complexes: in vitro and in vivo studies. MAGMA (2007) 0.78
Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review. Anal Chim Acta (2012) 0.78
Conformational behaviour determines the low-relaxivity state of a conditional MRI contrast agent. Phys Chem Chem Phys (2009) 0.78
Lectin-Gd-loaded chitosan hydrogel nanoparticles: a new biospecific contrast agent for MRI. Mol Imaging Biol (2011) 0.76
The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer (2005) 2.83
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene (2003) 2.56
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet (2006) 2.33
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med (2012) 2.02
BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene (2005) 1.62
Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. Biochim Biophys Acta (2005) 1.42
Multivalent glycoconjugates as anti-pathogenic agents. Chem Soc Rev (2012) 1.41
Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expression. Proc Natl Acad Sci U S A (2007) 1.41
Gold glyconanoparticles as new tools in antiadhesive therapy. Chembiochem (2004) 1.25
Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions This work was supported by the DGICYT (PB96-0820), J.M.F. thanks the MEC for a predoctoral fellowship. A.G.B. thanks CSIC for financial support. We thank Prof. Martín-Lomas for his scientific and financial support. Angew Chem Int Ed Engl (2001) 1.21
Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer (2004) 1.18
Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. Chemistry (2003) 1.14
Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev (2013) 1.13
Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick C mice. J Neurosci Res (2005) 1.12
Lanosterol and cholesterol-induced variations in bilayer elasticity probed by 2H NMR relaxation. Langmuir (2004) 1.06
Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydr Res (2006) 1.06
Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol Adv (2012) 1.05
NMR elastometry of fluid membranes in the mesoscopic regime. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.02
Nanostructured disposable impedimetric sensors as tools for specific biomolecular interactions: sensitive recognition of concanavalin A. Anal Chem (2011) 1.01
Uncovering of intracellular water in cultured cells. Magn Reson Med (2005) 1.00
Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice. PLoS One (2013) 0.98
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. Chemistry (2009) 0.98
Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer. Cancer Causes Control (2009) 0.97
Thermodynamic evidence for Ca2+-mediated self-aggregation of Lewis X gold glyconanoparticles. A model for cell adhesion via carbohydrate-carbohydrate interaction. J Am Chem Soc (2005) 0.97
Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. Hum Mol Genet (2004) 0.95
Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. Bioconjug Chem (2012) 0.95
Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin. Int J Cancer (2005) 0.95
Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells. Chembiochem (2009) 0.94
Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12. J Mol Biol (2011) 0.94
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine. Nanomedicine (Lond) (2012) 0.93
A model system mimicking glycosphingolipid clusters to quantify carbohydrate self-interactions by surface plasmon resonance. Angew Chem Int Ed Engl (2002) 0.93
Understanding carbohydrate-carbohydrate interactions by means of glyconanotechnology. Glycoconj J (2004) 0.90
Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J Control Release (2011) 0.90
Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem (2010) 0.89
Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells. J Med Genet (2006) 0.89
Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury. Brain Pathol (2011) 0.89
Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN. ACS Chem Biol (2013) 0.89
Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor. PLoS One (2012) 0.88
Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumours. NMR Biomed (2011) 0.88
Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents. Bioorg Med Chem Lett (2010) 0.88
Depressed glucose consumption at reperfusion following brain ischemia does not correlate with mitochondrial dysfunction and development of infarction: an in vivo positron emission tomography study. Curr Neurovasc Res (2009) 0.87
Glyconanoparticles: multifunctional nanomaterials for biomedical applications. Nanomedicine (Lond) (2010) 0.87
Modular protein engineering in emerging cancer therapies. Curr Pharm Des (2009) 0.86
Self-assembled multifunctional Fe/MgO nanospheres for magnetic resonance imaging and hyperthermia. Nanomedicine (2009) 0.86
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours. Hum Mol Genet (2009) 0.86
Nanoparticles as nonviral gene delivery vectors. IEEE Trans Nanobioscience (2007) 0.86
Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. Gastroenterology (2009) 0.86
Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target. J Biol Chem (2012) 0.85
68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J Am Chem Soc (2013) 0.85
In vivo proton magnetic resonance spectroscopy of intraventricular tumours of the brain. Eur Radiol (2009) 0.85
Glyconanotechnology. Chem Soc Rev (2013) 0.85
Multivalent gold glycoclusters: high affinity molecular recognition by bacterial lectin PA-IL. Chemistry (2012) 0.85
Development of a predictor for human brain tumors based on gene expression values obtained from two types of microarray technologies. OMICS (2010) 0.84
Modulating glycosidase degradation and lectin recognition of gold glyconanoparticles. Carbohydr Res (2009) 0.84
Netrin1 exerts a chemorepulsive effect on migrating cerebellar interneurons in a Dcc-independent way. Mol Cell Neurosci (2006) 0.84
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations. Mol Cancer (2014) 0.83
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma. NMR Biomed (2014) 0.82
Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI. Integr Biol (Camb) (2011) 0.82
Strategies for annotation and curation of translational databases: the eTUMOUR project. Database (Oxford) (2012) 0.82
Double addition of grignard reagents to N-glycosyl nitrones: a new tool for the construction of enantiopure azaheterocycles. Org Lett (2005) 0.82
A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands. Chemistry (2011) 0.81
RSR-2, the Caenorhabditis elegans ortholog of human spliceosomal component SRm300/SRRM2, regulates development by influencing the transcriptional machinery. PLoS Genet (2013) 0.81
Magnetic glyconanoparticles as a versatile platform for selective immunolabeling and imaging of cells. Bioconjug Chem (2011) 0.81
Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars. Chem Commun (Camb) (2009) 0.81
Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A. Appl Microbiol Biotechnol (2015) 0.81
Specific labelling of cell populations in blood with targeted immuno-fluorescent/magnetic glyconanoparticles. Biomaterials (2011) 0.81
In vivo assessment of neurodegeneration in Niemann-Pick type C mice by quantitative T2 mapping and diffusion tensor imaging. J Magn Reson Imaging (2011) 0.81
Higher processing rates of Alu-containing sequences in kidney tumors and cell lines with overexpressed Alu-mRNAs. Oncol Rep (2003) 0.80
Molecular patterns of nuclear and mitochondrial microsatellite alterations in breast tumors. Oncol Rep (2003) 0.80
Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes. Methods Enzymol (2012) 0.80
Characterization of the wheat germ agglutinin binding to self-assembled monolayers of neoglycoconjugates by AFM and SPR. Glycobiology (2009) 0.80
Short-term temperature effect on the HRMAS spectra of human brain tumor biopsies and their pattern recognition analysis. MAGMA (2010) 0.80
Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiation. MAGMA (2012) 0.79
Keratin 7 promoter selectively targets transgene expression to normal and neoplastic pancreatic ductal cells in vitro and in vivo. FASEB J (2009) 0.79
A quantitative study of the intracellular dynamics of fluorescently labelled glyco-gold nanoparticles via fluorescence correlation spectroscopy. Small (2014) 0.79
Generation and characterization of orthotopic murine models for endometrial cancer. Clin Exp Metastasis (2011) 0.79
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression. Mol Cancer (2014) 0.79
Brain magnetic resonance in experimental acute-on-chronic liver failure. Liver Int (2013) 0.79
Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles. Bioconjug Chem (2014) 0.78
Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy. Langmuir (2012) 0.78
High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles. PLoS One (2013) 0.78
NMR studies on the conformation of oligomannosides and their interaction with banana lectin. Glycoconj J (2007) 0.78